$CWNM .11 News out Crown Marketing Patents Approved in

New Post Public Reply Private Reply Replies (0) Message Board
jstops

[b]$CWNM[/b] .11 News out Crown Marketing Patents Approved in Mexico

CHAPEL HILL, NC, Feb 20, 2013 (MARKETWIRE via COMTEX) -- Crown Marketing (OTCQB: CWNM) is pleased to announce that patents for its Controlled Drug Delivery Technology (CDDT) have been approved and registered in Mexico.

Mexico's pharmaceutical industry faces unique challenges. According to an American Enterprise Institute study, Mexico's $15.5 billion market is plagued by counterfeit goods. Illicit activity in Mexico's pharmaceutical industry is estimated at roughly USD 1.9 billion per year -- with counterfeiting representing 81 percent of that illicit market. This is a situation where Crown believes its unique technology could have a significant impact.

In addition to protecting Crown's interest in Mexico's burgeoning market, Crown believes that its drug delivery device would significantly inhibit the ability to counterfeit medications due to its unique form and process of manufacture.

The intellectual property supporting the Controlled Drug Delivery Technology (CDDT) is comprehensively formulated to allow for the broad application of the technology with regard to the mode of administration, the desired release pattern, the type of compounds employed and the dosage form.

The technology can be employed to regulate time to first release of drug, the extent of the initial bolus release and the duration of the remaining controlled release. These programmable release profiles may be adjusted for considerations given to the different gastric and intestinal environments.

Crown's patent portfolio continues to increase as it is pursuing novel applications of its drug delivery technology.

About The Company:

Crown Marketing Crown's Controlled Drug Delivery Technology (CDDT) is a novel controlled-release technology, harnessing the principles diffusion through precise mathematical formulas. The spectrum and reliability of pharmacokinetic profiles achievable with this technology is superior to currently marketed formulations. Its simple design allows for a high level of flexibility in matching chronotherapeutic requirements. Cost-efficiencies in the commercial manufacturing process, when compared to other drug delivery technologies, may constitute its most important competitive advantage.

The objective of intelligent drug delivery design amounts to maximizing the percent of the time drug plasma levels are within the therapeutic range and avoiding patient exposure to potentially toxic (High) or sub-therapeutic (Low) levels.

Crown's cost-effective application of controlled delivery technologies will play a major role in the expansion of the pharmaceutical, OTC and nutraceuticals industry through our ability to improve on the performance of immediate release products in a manner tangible to manufacturers and consumers.

More information can be found at: www.crowncddt.com

This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approvals for anticipated actions.

Contact:

Charles Van Der Ross

347-491-0565

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Domino's Probe Puts Franchise Disclosure Under Lens

Updated Category News Views 201

A franchisee's shuttered stores can turn cheerful unit-growth talk into a nasty accounting of credibility, and that is the uncomfortable territory Domino's now occupies. Kahn Swick & Foti has opened an investigation into whether Domino's officers and directors breached fiduciary duties or violated state or federal law. That is not a finding of misconduct. It is a legal...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 161

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
Charter Investigation Puts ACP Exit Claims Under Lens

Updated Category News Views 264

Charter’s ACP hangover has grown from an operating headache into a governance question. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether Charter Communications officers or directors breached fiduciary duties or otherwise broke state or federal law. That is not a finding of wrongdoing, and investors ought to keep that distinction...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 215

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 383

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 176

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 199

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 329

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 255

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 154

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Alliance to Combat Crypto Crime and Aid Victims

Updated Category News Views 171

Asset Reality and Operation Shamrock Join Forces In a groundbreaking development in the fight against crypto crime, Asset Reality has formed a strategic alliance with Operation Shamrock. This collaboration comes as recent international guidance from the Financial Action Task Force (FATF) emphasizes the need for enhanced asset recovery strategies. The partnership aims to...

Continue Reading
Experience the Charm of Seaside with Exclusive Wine Festival Offer

Updated Category News Views 213

Exciting Wine Festival Promotion in Seaside The Homeowner's Collection is thrilled to announce an exclusive promotion just in time for the much-anticipated Seeing Red Wine Festival. This event, celebrated for its vibrant atmosphere and diverse selection of wines, will allow fans and newcomers to indulge in a remarkable experience while enjoying Seaside’s finest...

Continue Reading
Deckers Brands Prepares for Q2 Fiscal 2025 Earnings Call Review

Updated Category News Views 79

Deckers Brands Prepares for Upcoming Earnings Call Deckers Brands (NYSE: DECK), a prominent player in the footwear, apparel, and accessories industry, has recently announced an important conference call to review its financial performance for the second quarter of fiscal 2025. This call is scheduled to take place on a Thursday at approximately 4:30 p.m. Eastern Time....

Continue Reading
Prospect Capital Prepares for Upcoming Earnings Conference Call

Updated Category News Views 205

Prospect Capital Plans Earnings Release and Conference Call NEW YORK — Prospect Capital Corporation (NASDAQ: PSEC) has announced its upcoming earnings report for the fiscal quarter that ended on September 30, 2024. The company is set to file its Form 10-Q with the Securities and Exchange Commission, releasing their quarterly results on the following Friday. This marks...

Continue Reading
Pluxee Expands Employee Benefits with Benefício Fácil Acquisition

Updated Category News Views 285

Pluxee Strengthens Its Presence in Brazil Through Strategic Acquisition Pluxee has made a significant move to solidify its operations in Brazil by acquiring 100% of Benefício Fácil, a leading provider of employee mobility benefits. This acquisition marks a pivotal step in reinforcing Pluxee’s position within the dynamic Brazilian market. Details of the Acquisition The...

Continue Reading